Your inputs
FDA-approved for chronic weight management. Most commonly prescribed for weight loss.
120 lbs400 lbs
Phase 3 subgroup data: women lose ~2–4% more body weight than men. Skip to use the population average.
ftinBMI 33.4 (obese class I)
✓ Insurance eligibility: Most insurers cover Wegovy/Zepbound at this BMI. Prior auth still required, but you meet the standard threshold.
months (custom, 1–60)
Your projection
Total cost
$5,388
$449/mo × 12
Expected weight loss
28 lbs
12.7% of body weight
Final weight
192 lbs
from 220 lbs
Cost per pound lost
$192
lower is better
Weight loss curve modeled from STEP-1 phase 3 trial. Real-world results vary.
Save your projection or share it on Reddit/X — friends can run the same numbers.
Weight loss over time
Pounds lost based on trial data
Cumulative cost
What you'll have spent by each month
How 12-month projections compare across all GLP-1s
| Drug | Monthly | Total cost | Weight loss | $/lb lost |
|---|---|---|---|---|
| Zepbound | $499 | $5,988 | 41.4 lbs (18.8%) | $145 |
| Mounjaro | $499 | $5,988 | 38.5 lbs (17.5%) | $156 |
| Wegovy | $449 | $5,388 | 28 lbs (12.7%) | $192 |
| Wegovy (oral 25mg) | $449 | $5,388 | 25.5 lbs (11.6%) | $211 |
| Ozempic | $399 | $4,788 | 21.8 lbs (9.9%) | $220 |
| Saxenda | $399 | $4,788 | 16.7 lbs (7.6%) | $287 |
Sorted by cost-efficiency (lowest $/lb lost first). Some drugs may not be available on the selected payment channel.
For educational purposes only. Not medical advice.Powered by glp1cost.org →